This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BROMPHEN-PSE-DM 2-30-10 MG/5ML 473ML, a pharmaceutical product, with a ceiling value of $1,194.00. The contract is a firm fixed price, non-set-aside delivery order with a completion date of June 26, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the supply of pharmaceutical products and medical supplies to the DLA's Pharmaceutical Division - Force Sustainment Branch. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $549,692.46, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm-fixed price delivery order, with an ultimate completion date of May 5, 2025. Amerisourcebergen Drug Corp is the prime contractor, and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,505.36, is for the supply of various pharmaceutical products and medical supplies to support military healthcare programs. It is a firm fixed-price contract with a period of performance through May 15, 2025. The contract is not set aside for any small business or socioeconomic category....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,492.76, is a firm-fixed-price delivery order with an ultimate completion date of April 29, 2025. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a firm fixed price of $1,596.60 and an ultimate completion date of June 4, 2025, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $886,295.96, is for the delivery of a range of pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $39,715.48, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. It is a firm fixed-price contract with an ultimate completion date of June 20, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,072,901.75, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm fixed-price, non-set-aside arrangement with a performance period ending on December 26, 2024. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,747,753.53, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. It is a firm fixed-price contract with a performance period ending on May 19, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...